Potential Mechanisms and Effects of Chinese Medicines in Treatment of Diabetic Atherosclerosis by Modulating NLRP3 Inflammasome: A Narrative Review.
10.1007/s11655-022-3513-4
- Author:
Jia-Yao YUAN
1
;
Yu FU
2
,
3
;
Zhi-Hai FENG
4
;
Feng SANG
5
;
Ming-Yi SHAO
6
;
Lei-Lei LI
1
Author Information
1. School of First Clinical, Henan University of Chinese Medicine, Zhengzhou, 450000, China.
2. Department of Endocrinology, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, 450000, China. kybfuyu@
3. com.
4. Department of Endocrinology, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, 450000, China.
5. Department of Key Laboratory of Viral Diseases Prevention and Treatment of Traditional Chinese Medicine of Henan Province, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, 450000, China.
6. Department of Gastroenterology, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, 450000, China.
- Publication Type:Review
- Keywords:
Chinese medicine;
NLRP3 inflammasome;
TXNIP;
diabetic atherosclerosis;
interleukin-1β;
pyroptosis
- MeSH:
Atherosclerosis/drug therapy*;
China;
Diabetes Mellitus/drug therapy*;
Humans;
Inflammasomes/metabolism*;
Interleukin-1beta/metabolism*;
NLR Family, Pyrin Domain-Containing 3 Protein/metabolism*
- From:
Chinese journal of integrative medicine
2022;28(8):753-761
- CountryChina
- Language:English
-
Abstract:
Nucleotide-binding oligomerization domain-like receptor family pyrin domain-containing 3 (NLRP3) is an intracellular sensor that detects endogenous danger signals and environmental irritants to assemble into the NLRP3 inflammasome. Activation of the NLRP3 inflammasome leads to the secretion of the proinflammatory cytokines interleutkin (IL)-1β and IL-18 and induces pyroptosis. Recent studies have shown that the NLRP3 inflammasome participates in the initiation and progression of diabetic atherosclerosis through pathological mechanisms such as β-cell dysfunction, insulin resistance, endothelial cell dysfunction, monocyte adhesion and infiltration, and smooth muscle cell proliferation and migration. In diabetic atherosclerosis, Chinese medicine has been proven effective for the inflammatory response mediated by the NLRP3 inflammasome. This review summarizes the latest progress on the NLRP3 inflammasome in the pathogenesis and potential Chinese medicine treatment of diabetic atherosclerosis.
